Rapid regression of coronary dilatation in Kawasaki disease with intravenous gamma-globulin
- PMID: 1705749
- DOI: 10.1016/0002-8703(91)90207-x
Rapid regression of coronary dilatation in Kawasaki disease with intravenous gamma-globulin
Similar articles
-
Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.J Pediatr. 1988 Aug;113(2):290-4. doi: 10.1016/s0022-3476(88)80267-1. J Pediatr. 1988. PMID: 2456378
-
High-dose intravenous gamma-globulin therapy in Kawasaki disease.Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1989 Jan-Feb;30(1):15-22. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1989. PMID: 2484055
-
Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities.Am J Cardiol. 1991 Sep 15;68(8):796-7. doi: 10.1016/0002-9149(91)90658-8. Am J Cardiol. 1991. PMID: 1716411 No abstract available.
-
What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada?Pediatr Infect Dis J. 1988 Jul;7(7):463-6. doi: 10.1097/00006454-198807000-00001. Pediatr Infect Dis J. 1988. PMID: 2457202 Review. No abstract available.
-
New developments in Kawasaki disease.Curr Opin Rheumatol. 1991 Feb;3(1):46-55. doi: 10.1097/00002281-199102000-00009. Curr Opin Rheumatol. 1991. PMID: 1710476 Review.
Cited by
-
Intravenous immunoglobulin for the treatment of Kawasaki disease in children.Cochrane Database Syst Rev. 2003;2003(4):CD004000. doi: 10.1002/14651858.CD004000. Cochrane Database Syst Rev. 2003. PMID: 14584002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical